A Study in Participants With Moderate to Severe Psoriasis (Q63833953)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Study in Participants With Moderate to Severe Psoriasis |
clinical trial |
Statements
A Dose-Ranging And Efficacy Study of LY2439821 (An Anti-IL-17 Antibody) In Patients With Moderate-To-Severe Psoriasis (English)
0 references
April 2010
0 references
January 2011
0 references
142
0 references
18 year
0 references